Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- ChecktodayChange DetectedThe page’s footer revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov site release rather than a change to the trial record content.SummaryDifference0.0%

- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a system-level update with no visible changes to the study details or other user-facing content.SummaryDifference0.0%

- Check72 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2; no impact on study content or page usability.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision metadata was updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.